PATIENT INFORMATION LEAFLET

Size: px
Start display at page:

Download "PATIENT INFORMATION LEAFLET"

Transcription

1 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 PATIENT INFORMATION LEAFLET Page 1 f 9

2 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP * rifampicin, isniazid, pyrazinamide, ethambutl Read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant infrmatin fr yu. - Keep this leaflet; yu may need t read it again. - If yu have any further questins, please ask the dctr, health care prvider r pharmacist. - This medicine has been prescribed fr yu nly. D nt pass it n t thers. It may harm them, even if the signs f their illness are the same as yurs. - If any f the side effects gets serius, r if yu ntice any side effects nt listed in this leaflet, please tell the dctr, health care prvider r pharmacist What is in this leaflet: 1. What Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP is and what it is used fr 2. What yu need t knw befre yu take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP 3. Hw t take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP 4. Pssible side effects 5. Hw t stre Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP 6. Cntents f the pack and ther infrmatin 1. WHAT RIFAMPICIN 150 mg/isoniazid 75 mg/pyrazinamide 400 mg/ethambutol HYDROCHLORIDE 275 mg TABLETS USP IS AND WHAT IT IS USED FOR Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP is used fr the initial treatment f tuberculsis. Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP cntains the active substances ethambutl, isniazid, pyrazinamide, and rifampicin. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE RIFAMPICIN 150 mg/isoniazid 75 mg/pyrazinamide 400 mg/ethambutol HYDROCHLORIDE 275 mg TABLETS USP D nt take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP: if yu are allergic (hypersensitive) t - ethambutl, isniazid, pyrazinamide r rifamycins - any f the ingredients f Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP (see sectin 6, What Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets * Trade names are nt prequalified by WHO. This is the natinal medicines regulatry authrity s (NMRA) respnsibility. Thrughut this WHOPAR the prprietary name is given as an example nly. Page 2 f 9

3 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 USP cntains). if yu have acute liver prblems r previusly have had a liver prblem which was caused by drugs, including isniazid, rifampicin r pyrazinamide if yu have had serius side effects frm isniazid r rifampicin such as fever, chills r swelling f the jints if yu have prphyria if yu have acute guty arthritis if yu have severe kidney prblems if yu are taking any f the fllwing medicatins: - vricnazle used fr treating fungal infectin - prtease inhibitrs used fr treating HIV infectin. D nt take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP if any f the abve apply t yu. If yu are nt sure abut anything, ask yur dctr, pharmacist r health care prvider. Take special care with Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP Tell yur dctr r health care prvider if yu have any f the fllwing illnesses befre taking this medicine: Liver prblems and chrnic liver disease Kidney prblems Gut Diabetes mellitus Epilepsy HIV infectin Tingling f the hands and feet (peripheral neurpathy) and inflammatin f peripheral nerves r the ptic nerve (ptic neuritis) Eye defects Chrnic alchlism (drinking alchlic beverages daily) Underfeeding Als tell yur dctr r health care prvider if: yu are pregnant r think yu might be pregnant yu are allergic (hypersensitive) t niacin (nictinic acid) yu use injectin drugs (e.g. herin). Yu shuld nt take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP if yur weigh less than 30 kg. Yu shuld nt interrupt treatment with Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP withut checking with yur dctr r health care prvider. Yu shuld use additinal means f cntraceptin (e.g. barrier methd such as cndms) apart frm taking the pill as lng as yu take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP. Page 3 f 9

4 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 See sectin 4 (Pssible side effects) abut what yu must d if yu get certain side effects Taking ther medicines with Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP Tell yur dctr r health care prvider if yu are taking r have recently taken any ther medicines, including medicines btained withut a prescriptin. They may affect hw well Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP wrks r Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP may affect the way the ther medicines wrk. Yu must nt take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP with any f the fllwing medicatins: vricnazle (used fr treating fungal infectin) prtease inhibitrs (used fr treating HIV infectin) Yu shuld als nt take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP with any f the fllwing medicatins: nevirapine (used fr treating HIV infectin) simvastatin (used fr reducing chlesterl) aluminium hydrxide (used fr treating stmach disrders) disulfiram (used in the treatment f alchlism) Tell yur dctr als if yu take ne f the fllwing: Medicines fr HIV infectin like efavirenz, zidvudine, stavudine Medicines t treat fungal infectins like ketcnazle flucnazle and terbinafine Antibitics like chlramphenicl and clarithrmycin Medicines fr malaria like atvaqune and quinine Medicines t suppress the immune system like ciclsprin and tacrlimus Medicines fr heart cnditins like digxin, lidcaine and verapamil Medicines fr bld pressure like amldipine and atenll Medicines fr diabetes like glibenclamide Oral cntraceptive pill r ther hrmnal cntraceptives Medicines fr gut like prbenecid Medicines fr epilepsy like carbamazepine, phenytin and valprate Medicines fr anxiety and sleeping disrders like diazepam Medicines fr depressin like amitriptyline and fr psychiatric cnditins like chlrprmazine and halperidl Medicines t prevent bld clts like warfarin Medicines used during surgery like enflurane Crticsterids like prednislne Hrmne treatments like thyrid hrmnes Medicines fr pain like paracetaml and piids like cdeine and mrphine Aminsalicylic acid (als called para-aminsalicylic acid, a medicine fr tuberculsis), Methadne (a medicine fr herin addicts) Page 4 f 9

5 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 Taking Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP with fd and drink Take this medicine n an empty stmach at least ne hur befre a meal r tw hurs after a meal. D nt drink any alchl as lng as yu are taking Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP. Yu shuld avid fd which cntains a large amunt f tyramine (like cheese, red wine) r f histamine (like tuna fish). Taking such fd while yu are being treated with Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP may cause effects such as headache, punding heartbeat, lightheadedness, sweating, itching and flushing. Pregnancy and breastfeeding Tell yur dctr r healthcare prvider as sn as pssible if yu are pregnant r think yu are pregnant. Yur dctr r healthcare prvider will help yu decide if it is pssible t cntinue treatment with Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP. If yu take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP during pregnancy, yur dctr r healthcare prvider shuld give yu pyridxine (vitamin B 6 ) supplements during pregnancy and vitamin K supplements during the last mnth f pregnancy. This medicine ges int breast milk but the amunt is t lw t prtect the breast-fed baby against tuberculsis. The medicine has nt been reprted t harm breast-fed babies f mthers taking the medicine. Tell yur dctr r healthcare prvider if yu are breast-feeding r if yu intend t breastfeed while taking Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP. Driving and using machines Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP can cause side effects such as dizziness, cnfusin and blurred visin. This may make yu less able t drive r d certain things like using machines. 3. HOW TO TAKE RIFAMPICIN 150 mg/isoniazid 75 mg/pyrazinamide 400 mg/ethambutol HYDROCHLORIDE 275 mg TABLETS USP Always take this medicine exactly as yur dctr r healthcare prvider has tld yu. Yu shuld check with yur dctr, healthcare prvider r pharmacist if yu are nt sure. These dses are fr adults weighing mre than 30 kg and fr children weighing kg. Children weighing less than this shuld nt take these tablets. Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP shuld be taken n any empty stmach at least 1 hur befre a meal r 2 hurs after a meal. Swallw the tablets whle with a drink f water. The dse f Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP yu need t take depends n yur bdy weight. The usual dse fr an adult is as fllws: Page 5 f 9

6 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 Yur bdy weight Dse kg take 2 tablets nce each day kg take 3 tablets nce each day kg take 4 tablets nce each day Mre than 70 kg take 5 tablets nce each day Fr children weighing kg the dse is 2 tablets nce each day. Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP shuld be given nly t children wh can swallw whle tablets. If yu have kidney disease, yur dctr r healthcare prvider may prescribe the ingredients f this medicine separately. Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP is nt recmmended fr adults with a bdy weight belw 30 kg. Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP is usually given fr 2 mnths at the beginning f tuberculsis treatment but yur dctr r healthcare prvider will decide n hw lng yu need t take this medicine. If yu take mre Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP than yu shuld If yu accidentally take an extra tablet, nthing is likely t happen. If yu accidentally take several tablets t many, cntact yur dctr r healthcare prvider r talk t yur nearest hspital casualty department immediately. If pssible, take yur tablets r the cntainer with yu t shw the dctr r health care prvider what yu have taken. Taking t many tablets can cause vmiting, stmach upset, fever, headache, dizziness, slurred speech, hallucinatins and prblems with visin. If yu frget t take Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP If yu frget t take a dse, take it as sn as pssible. Hwever, if yur next dse within 6 hurs, skip the missed dse and take the next tablet at the usual time. Yu shuld nt take a duble dse t make up fr a missed dse. If yu stp taking Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP Always keep taking the tablets until the curse is finished, even if yu feel better. If yu stp taking the tablets t sn, the infectin may cme back. Als, the bacteria may becme resistant t the medicine, making it mre difficult t treat the infectin. If yu have any further questins n the use f this prduct, ask the dctr, health care prvider r pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP can cause side effects, but nt everybdy gets them. Tell yur dctr r healthcare prvider abut any change in yur health. Page 6 f 9

7 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 Serius side effects If yu have any f the fllwing symptms f a severe allergic reactin, stp taking this medicine and tell yur dctr r healthcare prvider immediately r g t the casualty department at yur nearest hspital: Sudden difficulty in breathing, speaking and swallwing Swelling f lips, tngue, face r neck Extreme dizziness r cllapse Severe r itchy skin rashes, especially if this shws blistering and there is sreness f the eyes, muth r genital rgans If yu get any f the fllwing side effects cntact yur dctr r healthcare prvider as sn as pssible: Diarrhea that is serius, lasts a lng time r has bld in it with stmach pain r fever: This can be a sign f serius bwel inflammatin. Bruising r unusual bleeding; if yu cntinue taking Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP, yu are at risk f brain haemrrhage (bleeding) Yellwing f the skin r whites f the eyes, r urine getting darker and stls paler, fatigue, weakness, lss f appetite, nausea r vmiting these are signs f liver prblems (hepatitis). Inflammatin f the pancreas, which causes severe pain in the abdmen and back (pancreatitis). Visin disturbances like blurred visin, eye pain, red-green clur blindness r even lss f visin. Reduced white bld cells, accmpanied by sudden high fever, severe sre thrat and ulcers in the muth (agranulcytsis). These are all serius side effects. Yu may need urgent medical attentin. Serius side effects are rare (affect fewer than 1 in 1000 peple) r very rare (affect fewer than 1 in peple). Other cmmn side effects (These can affect at least 1 in every 100 patients treated, but fewer than 1 in every 10 patients treated) Tiredness, drwsiness, headache, lightheadedness, dizziness Tingling, pricking r numbness (peripheral neurpathy) yur dctr r healthcare prvider may prescribe pyridxine (vitamin B6) t prevent these effects Reddish disclratin f bdy fluids and secretins like urine, tear fluid, sweat, sputum, stls and saliva Reddening f the eyes, permanent disclratin f sft cntact lenses Nausea, vmiting, lss f appetite, abdminal discmfrt and pain, blatedness Flushing, itching with r withut skin rash, nettle rash Allergic r ther reactins like skin rash, fever, muscle r jint pain Lss f appetite, nausea, vmiting, fatigue, malaise and weakness indicating liver prblems Bld test shwing increase in liver enzymes Increase in bld uric acid, acute guty arthritis (chills, pain and swelling f jints, especially big te, ankle r knee) Uncmmn side effects (These can affect at least 1 in every 1000 patients treated, but fewer than 1 in every 100 patients treated) Page 7 f 9

8 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB193 Hallucinatins, disrientatin, cnfusin, malaise Rare side effects (These can affect at least 1 in every patients treated, but less than 1 in every 1000 patients treated) Changes f white and red bld cell cunt, changes f platelet cunt, anaemia, disrders f bld cltting, swelling f spleen Oedema r swelling because f water retentin Breathing difficulty and inflammatin f the lungs Metalic taste, diarrhea, flatulence Menstrual disturbances, swelling f breast tissue in men, early puberty, difficulties in diabetes cntrl, high bld sugar, Cushing s syndrme (disease caused by increase f crticsterid hrmnes), inductin f crisis in Addisn s patients (patients with a special frm f hrmnal disrder) Psychsis, hyperactivity, euphria, sleeplessness, cnvulsins Muscle weakness, prblems with c-rdinatin f mvement (ataxia), increase in seizure frequency in patients with epilepsy Disturbances f visin, damage t the ptic nerve (ptic neuritis) Gastritis, jaundice, enlargement and inflammatin f the liver (in rare cases severe) Allergic and ther reactins like dry muth, heartburn, urinatin disrders, rheumatic syndrmes and symptms Pellagra (characterised by gastrintestinal disturbances, reddening f skin, nervus and mental disrders), swelling f lymph ndes, acne, skin rash, light sensitivity Raised kidney enzymes, acute kidney failure, inflammatin f the kidney, prblems with urinatin Inductin f prphyria (a grup f disrders characterised by sensitivity t light, skin lesins, anaemia, psychsis and acute abdminal pain) If yu start taking Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP again after interrupting treatment, a s-called influenza-like syndrme may ccur. It is characterised by fever, shivering and pssibly headache, dizziness, bne and muscle pain. In rare cases bleeding int the skin, breathing difficulties, asthma-like attacks, anaemia, shck and kidney failure might develp. If any f the side effects get serius r if yu ntice any side effects nt listed in this leaflet tell yur dctr, healthcare prvider r pharmacist. 5. HOW TO STORE RIFAMPICIN 150 mg/isoniazid 75 mg/pyrazinamide 400 mg/ethambutol HYDROCHLORIDE 275 mg TABLETS USP Keep ut f the sight and reach f children. Stre belw 25 C, in a dry place. Prtect frm light D nt use Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP after the expiry date stated n the bttle r cartn. The expiry date refers t the last day f that mnth. Medicines shuld nt be dispsed f in wastewater r husehld waste. Ask yur pharmacist hw t dispse f medicines yu n lnger use. These measures will help t prtect the envirnment. Page 8 f 9

9 Ethambutl Hydrchlride/Isniazid/Pyrazinamide/ (Svizera Eurpe BV), TB CONTENTS OF THE PACK AND OTHER INFORMATION What Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP cntains The active ingredients f Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP are: Rifampicin 150 mg Isniazid 75 mg Pyrazinamide 400 mg Ethambutl hydrchlride 275 mg The ther ingredients are: Cre tablet: cllidal silicn dixide, crscarmellse sdium, irn xide red, magnesium stearate, maize starch, micrcrystalline cellulse, purified talc and sdium starch glyclate. Film cat (OPADRY II 31K58902 white): hydrxyprpyl methylcellulse, irn xide red, plyethylene glycl, purified talc and titanium dixide. What Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP lks like and cntents f the pack Rifampicin 150 mg/isniazid 75 mg/pyrazinamide 400 mg/ethambutl Hydrchlride 275 mg Tablets USP are pinkish-brwn, blng, bicnvex, film-cated tablets with a break-line n ne side, supplied as: 1000 tablets packed in plyprpylene bag, packed tgether with a silica gel desiccant in a white square HDPE bttle with aluminium inductin seal and white plyprpylene cap tablets in red PVDC/aluminium blisters Supplier Svizera Eurpe BV Antennestraat 43 P.O. Bx AY Almere The Netherlands Tel: +31 (0) Fax:+31 (0) inf@svizera.rg Manufacturer Svizera Labs Private Ltd Plt D-16/6, TTC Industrial Area Turbhe Navi Mumbai India Tel: Fax: svizera@vsnl.net This leaflet was last apprved in September Detailed infrmatin n this medicine is available n the Wrld Health Organizatin (WHO) web site: Page 9 f 9

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to: PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically

More information

MEDICATION GUIDE. (canagliflozin) Tablets

MEDICATION GUIDE. (canagliflozin) Tablets MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems. PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr

More information

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur

More information

MEDICATION GUIDE. (fingolimod) capsules

MEDICATION GUIDE. (fingolimod) capsules MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the

More information

MEDICATION GUIDE. Reference ID:

MEDICATION GUIDE. Reference ID: MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.

More information

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride

More information

If you have any doubts or queries about your medication, please contact your doctor or pharmacist.

If you have any doubts or queries about your medication, please contact your doctor or pharmacist. Bayer plc Bayer Huse Strawberry Hill Newbury Berkshire RG14 1JA United Kingdm Telephne: +44 (0)1635 563 000 Facsimile: +44 (0)1635 563 393 Cmpany Web Site: http://www.bayer.c.uk Due t regulatry changes,

More information

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and

More information

Package leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate

Package leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet

More information

/0515 Medication Guide Aripiprazole Tablets

/0515 Medication Guide Aripiprazole Tablets 8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This

More information

PACKAGE LEAFLET INFORMATION FOR THE PATIENT

PACKAGE LEAFLET INFORMATION FOR THE PATIENT PACKAGE LEAFLET INFORMATION FOR THE PATIENT AMPICILLIN 125mg/5ml and 250mg/5ml ORAL SUSPENSION Please read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant infrmatin

More information

Read all of this leaflet carefully before you start taking this medicine.

Read all of this leaflet carefully before you start taking this medicine. Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet

More information

New Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)

New Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml) New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully

More information

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new

More information

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII) Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause

More information

MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?

MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID? MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins

More information

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.

More information

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets MEDICATION GUIDE XARELTO (zah-rel-te) (rivarxaban) tablets Read this Medicatin Guide befre yu start taking XARELTO and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER 1 ethambutol hydrochloride Read all of this leaflet carefully before your child starts taking this medicine

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII) MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.

More information

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant

More information

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets Medicatin Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets IMPORTANT: D nt use ABSTRAL unless yu are regularly using anther piid pain medicine arund-the-clck fr at least ne week r lnger fr yur

More information

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

o New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe.

o New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe. MEDICATION GUIDE FLUOXETINE CAPSULES, USP (fl xʹ e teen) 10 mg and 20 mg Read the Medicatin Guide that cmes with fluxetine capsules befre yu start taking it and each time yu get a refill. There may be

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

MEDICATION GUIDE. (Interferon alfa-2b)

MEDICATION GUIDE. (Interferon alfa-2b) MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP) My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made

More information

Package leaflet: Information for the user. CHAMPIX 0.5 mg film-coated tablets CHAMPIX 1 mg film-coated tablets Varenicline

Package leaflet: Information for the user. CHAMPIX 0.5 mg film-coated tablets CHAMPIX 1 mg film-coated tablets Varenicline Package leaflet: Infrmatin fr the user CHAMPIX 0.5 mg film-cated tablets CHAMPIX 1 mg film-cated tablets Varenicline Read all f this leaflet carefully befre yu start taking this medicine because it cntains

More information

MEDICATION GUIDE Levofloxacin (lee-voe-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets

MEDICATION GUIDE Levofloxacin (lee-voe-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets MEDICATION GUIDE Levflxacin (lee-ve-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets Read this Medicatin Guide befre yu start taking levflxacin tablets and each time yu get a

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

Tendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones.

Tendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones. Medicatin Guide LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION, 25 mg/ml and LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION in 5% Dextrse fr Intravenus Use Read this Medicatin Guide befre yu start taking levflxacin

More information

DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY

DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY YOU AND YOUR BODY DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY kk WHY IS THIS LEAFLET FOR YOU? Pancreatic excrine insufficiency (PEI) is imprtant t understand in diabetes care due t the changing functins

More information

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

PATIENT INFORMATION. (methotrexate) injection, for subcutaneous use

PATIENT INFORMATION. (methotrexate) injection, for subcutaneous use What is Rasuv? PATIENT INFORMATION RASUVO (ruh-soo-vh) (methtrexate) injectin, fr subcutaneus use Rasuv is a single-dse manually-triggered aut-injectr cntaining a prescriptin medicine, methtrexate. Methtrexate

More information

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET. PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Pyrazinamide 500 mg Tablets * Pyrazinamide Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

Suicidal thoughts or actions:

Suicidal thoughts or actions: MEDICATION GUIDE Venlafaxine (VEN la fax een) Hydrchlride Extended-release Capsules USP Read the Medicatin Guide that cmes with venlafaxine hydrchlride extended-release capsulesbefre yu start taking them

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER (Sanfi-Aventis France), NT001 Suppliers submissin f the SRA apprved text Octber 2016 Name f the medicinal prduct Text bx PACKAGE LEAFLET: INFORMATION FOR THE USER NOTEZINE 100 mg, scred tablets Diethylcarbamazine

More information

Patient Information Packet Date:

Patient Information Packet Date: Patient Infrmatin Packet Date: We knw paperwrk is nt fun, but thank yu s much fr taking the time! Last Name: First Name: MI Address: Phne: City State: Zip Cde: Mbile: D.O.B: / / Scial Security: / / Email:

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

PACKAGE LEAFLET. Ethambutol hydrochloride/isoniazid 400mg/150mg tablets WHOPAR part 3 07/2010, version 1.0 (Cadila Pharmaceuticals Ltd), TB009

PACKAGE LEAFLET. Ethambutol hydrochloride/isoniazid 400mg/150mg tablets WHOPAR part 3 07/2010, version 1.0 (Cadila Pharmaceuticals Ltd), TB009 PACKAGE LEAFLET Page 1 of 7 PACKAGE LEAFLET: INFORMATION FOR THE USER Ethambutol hydrochloride/isoniazid 400mg/150mg tablets * Read all of this leaflet carefully before you start taking this medicine.

More information

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth.

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth. MEDICATION GUIDE Oral Transmucsal Fentanyl Citrate (OTFC) CII (fentanyl citrate) ral transmucsal lzenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: D nt use Oral Transmucsal Fentanyl

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Closerine * Cycloserine 250 mg capsules Read all of this leaflet carefully before you start taking this medicine

More information

Do you have any of the symptoms listed below? Please circle all that apply.

Do you have any of the symptoms listed below? Please circle all that apply. D yu have any f the symptms listed belw? Please circle all that apply. Parkinsn s Symptms: Truble walking Falls Feet sticking t the flr Tremr Medicatins wearing ff Truble sleeping Vivid dreams Thrashing

More information

Medication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection

Medication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection Medicatin Guide SIGNIFOR [sig-na-fr] (pasiretide) Injectin Read this Medicatin Guide befre yu start using SIGNIFOR and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

Understanding Blood Counts

Understanding Blood Counts Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health

More information

MEDICATION GUIDE VIMOVO (vi-moh-voh) (naproxen and esomeprazole magnesium) Delayed Release Tablets

MEDICATION GUIDE VIMOVO (vi-moh-voh) (naproxen and esomeprazole magnesium) Delayed Release Tablets MEDICATION GUIDE VIMOVO (vi-mh-vh) (naprxen and esmeprazle magnesium) Delayed Release Tablets Read this Medicatin Guide befre yu start taking VIMOVO and each time yu get a refill. There may be new infrmatin.

More information

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,

More information

Package leaflet: Information for the patient Imuran Powder for Solution for Injection or Infusion 50mg azathioprine

Package leaflet: Information for the patient Imuran Powder for Solution for Injection or Infusion 50mg azathioprine Package leaflet: Infrmatin fr the patient Imuran Pwder fr Slutin fr Injectin r Infusin 50mg azathiprine Read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant

More information

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical

More information

WHO-PQ RECOMMENDED PATIENT INFORMATION LEAFLET

WHO-PQ RECOMMENDED PATIENT INFORMATION LEAFLET WHO-PQ RECOMMENDED PATIENT INFORMATION LEAFLET Page 1 of 10 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER filmcoated Tablets 1 Read all of this leaflet carefully before you start taking this medicine

More information

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Cycloserine Capsules USP 250 mg 1 Cycloserine Read all of this leaflet carefully before you start taking this

More information

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth. DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Isoniazid Tablets BP 100 mg * Isoniazid Read all of this leaflet carefully before you start taking this medicine.

More information

NEW PATIENT QUESTIONNAIRE-ADULT

NEW PATIENT QUESTIONNAIRE-ADULT 3700 WASHINGTON AVENUE EVANSVILLE, IN 47750 (812) 485-7680 NEW PATIENT QUESTIONNAIRE-ADULT PART 1. PATIENT INFORMATION Name Hme Phne Date f Birth Scial Security Number Wrk Phne Tday s Date Physicians Caring

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Medical History. Yes or No

Medical History. Yes or No Medical Histry Althugh dental persnnel primarily treat the area in and arund yur muth, yur muth is a part f yur entire bdy. Health prblems that yu may have, r medicatin that yu may be taking, culd have

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Asthma inhalers, medicines and treatments

Asthma inhalers, medicines and treatments Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Cycloserine 250 mg capsules * Cycloserine 250 mg capsules Read all of this leaflet carefully before you start

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Rifampicin 150 mg Capsules * rifampicin Read all of this leaflet carefully before you start taking this medicine.

More information

PATIENT INFORMATION. Last Name: First Name: Address: City/State/Zip: Phone: (H): (W): (C): Date of Birth: Gender: Male Female

PATIENT INFORMATION. Last Name: First Name: Address: City/State/Zip: Phone: (H): (W): (C):   Date of Birth: Gender: Male Female PATIENT INFORMATION Date Last Name: First Name: Address: City/State/Zip: Phne: (H): (W): (C): Email: Date f Birth: Gender: Male Female EMERGENCY CONTACT INFORMATION Last Name First Name Middle Initial

More information

NORVASC 5 mg and 10 mg tablets

NORVASC 5 mg and 10 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 8 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER AKuriT* Rifampicin/Isoniazid 150 mg/75 mg Tablets Read all of this leaflet carefully before you or your child

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 5 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Diethylcarbamazine Citrate Tablets 100 mg USP * (DEC Tablets) diethylcarbamazine citrate DIETHYLCARBAMAZINE

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 9 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Rifampicin/Isoniazid 300mg/150mg film-coated Tablets 1 rifampicin and isoniazid Read all of this leaflet carefully

More information

Advantage EAP Employee Assistance Program

Advantage EAP Employee Assistance Program Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Efexor XL 75 mg prolonged-release capsules, hard Efexor XL 150 mg prolonged-release capsules, hard

PACKAGE LEAFLET: INFORMATION FOR THE USER. Efexor XL 75 mg prolonged-release capsules, hard Efexor XL 150 mg prolonged-release capsules, hard PACKAGE LEAFLET: INFORMATION FOR THE USER Efexr XL 75 mg prlnged-release capsules, hard Efexr XL 150 mg prlnged-release capsules, hard Venlafaxine IMPORTANT THINGS YOU SHOULD KNOW ABOUT EFEXOR XL Please

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER TERAZOSIN ACCORD 1 mg TABLETS TERAZOSIN ACCORD 2 mg TABLETS TERAZOSIN ACCORD 5 mg TABLETS TERAZOSIN

PACKAGE LEAFLET: INFORMATION FOR THE USER TERAZOSIN ACCORD 1 mg TABLETS TERAZOSIN ACCORD 2 mg TABLETS TERAZOSIN ACCORD 5 mg TABLETS TERAZOSIN PACKAGE LEAFLET: INFORMATION FOR THE USER TERAZOSIN ACCORD 1 mg TABLETS TERAZOSIN ACCORD 2 mg TABLETS TERAZOSIN ACCORD 5 mg TABLETS TERAZOSIN Read all f this leaflet carefully befre yu start taking this

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan 20/120 * artemether/lumefantrine 20mg/120mg tablets Read all of this leaflet carefully before you start

More information

PHARYNGO-OESOPHAGECTOMY

PHARYNGO-OESOPHAGECTOMY PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Isoniazid Tablets BP 100 mg 1 Isoniazid Read all of this leaflet carefully before you start taking this medicine.

More information

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Imaging tests allow the cancer care team to check for cancer and other problems inside the body. IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu

More information

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

Pediatric Health History Form

Pediatric Health History Form Pediatric Health Histry Frm Child s Name Date f Birth Mther s Name Father s Name Parent Cncerns - Please explain any ther cncerns r questins yu have abut yur child Des yur child have any allergies? Yes

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 8 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Rifampicin/Isoniazid 60mg/60mg Dispersible Tablets * rifampicin, isoniazid Read all of this leaflet carefully

More information

XYZAL 5 MG FILM-COATED TABLET

XYZAL 5 MG FILM-COATED TABLET XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,

More information

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program? 3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 5 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Closerin * Cycloserine 250 mg capsules Read all of this leaflet carefully before you start taking this medicine

More information

PACKAGE LEAFLET. Page 1 of 10

PACKAGE LEAFLET. Page 1 of 10 PACKAGE LEAFLET Page 1 f 10 Package leaflet: Infrmatin fr the user Ireven 75 mg prlnged-release capsules, hard Ireven 150 mg prlnged-release capsules, hard Venlafaxine Read all f this leaflet carefully

More information

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injectin, fr Subcutaneus Use Single-Dse Prefilled Syringe 150 mg Read this Instructins fr Use befre yu start using ZINBRYTA and each time yu get

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Cycloserine Capsules Ph. Int. 250 mg 1 Cycloserine Read all of this leaflet carefully before you start taking

More information

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets PACKAGE LEAFLET Package Leaflet: Information for the user Methocarbamol 750mg Film-Coated Tablets Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

SANDOMIGRAN. 0.5mg tablet Pizotifen malate SANDOMIGRAN 0.5mg tablet Pizotifen malate What is in this leaflet This leaflet answers some common questions about Sandomigran. It does not contain all the available information. It does not take the place

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Dolutegravir 50 mg Tablets 1 Dolutegravir Read all of this leaflet carefully before you start giving this medicine

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Praziquantel 600mg Tablets 1* Read all of this leaflet carefully before you start taking this medicine because

More information

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC. SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking

More information

CRANIOFACIAL RESECTION

CRANIOFACIAL RESECTION CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.

More information